Taylor PL. Innovation incentives or corrupt conflicts of interest? Moving beyond Jekyll and Hyde in regulating biomedical academic-industry relationships. Yale J Health Policy Law Ethics. 2013; 13(1):135-97.
Harris ED, Ziniel SI, Amatruda JG, Clinton CM, Savage SK, Taylor PL, Huntington NL, Green RC, Holm IA. The beliefs, motivations, and expectations of parents who have enrolled their children in a genetic biorepository. Genet Med. 2012 Mar; 14(3):330-7.
Cassa CA, Savage SK, Taylor PL, Green RC, McGuire AL, Mandl KD. Disclosing pathogenic genetic variants to research participants: quantifying an emerging ethical responsibility. Genome Res. 2012 Mar; 22(3):421-8.
Taylor PL. Responsibility rewarded: ethics, engagement, and scientific autonomy in the labyrinth of the minotaur. Neuron. 2011 May 26; 70(4):577-81.
Kohane IS, Taylor PL. Multidimensional results reporting to participants in genomic studies: getting it right. Sci Transl Med. 2010 Jun 23; 2(37):37cm19.
Taylor PL, Barker RA, Blume KG, Cattaneo E, Colman A, Deng H, Edgar H, Fox IJ, Gerstle C, Goldstein LS, High KA, Lyall A, Parkman R, Pitossi FJ, Prentice ED, Rooke HM, Sipp DA, Srivastava A, Stayn S, Steinberg GK, Wagers AJ, Weissman IL. Patients beware: commercialized stem cell treatments on the web. Cell Stem Cell. 2010 Jul 2; 7(1):43-9.
Taylor PL. State payer mandates to cover care in US oncology trials: do science and ethics matter? J Natl Cancer Inst. 2010 Mar 17; 102(6):376-90.
Taylor PL. Overseeing innovative therapy without mistaking it for research: a function-based model based on old truths, new capacities, and lessons from stem cells. J Law Med Ethics. 2010; 38(2):286-302.
Zarzeczny A, Scott C, Hyun I, Bennett J, Chandler J, Chargé S, Heine H, Isasi R, Kato K, Lovell-Badge R, McNagny K, Pei D, Rossant J, Surani A, Taylor PL, Ogbogu U, Caulfield T. iPS cells: mapping the policy issues. Cell. 2009 Dec 11; 139(6):1032-7.
- Show all
Skene L, Testa G, Hyun I, Jung KW, McNab A, Robertson J, Scott CT, Solbakk JH, Taylor P, Zoloth L. Ethics report on interspecies somatic cell nuclear transfer research. Cell Stem Cell. 2009 Jul 2; 5(1):27-30.
Taylor PL. Retroactive ethics in rapidly developing scientific fields. Cell Stem Cell. 2009 Jun 5; 4(6):479-82.
Taylor PL. Scientific self-regulation-so good, how can it fail? Commentary on "The problems with forbidding science". Sci Eng Ethics. 2009 Sep; 15(3):395-406.
Taylor PL. The Ethics of Protocells—Moral and Social Implications of Creating Life in the Laboratory. American Journal of Human Genetics. 2009; 2(85):140-141.
Hyun I, Lindvall O, Ahrlund-Richter L, Cattaneo E, Cavazzana-Calvo M, Cossu G, De Luca M, Fox IJ, Gerstle C, Goldstein RA, Hermerén G, High KA, Kim HO, Lee HP, Levy-Lahad E, Li L, Lo B, Marshak DR, McNab A, Munsie M, Nakauchi H, Rao M, Rooke HM, Valles CS, Srivastava A, Sugarman J, Taylor PL, Veiga A, Wong AL, Zoloth L, Daley GQ. New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell. 2008 Dec 4; 3(6):607-9.
Taylor P. Personal genomes: when consent gets in the way. Nature. 2008 Nov 6; 456(7218):32-3.
Bourgeois FC, Taylor PL, Emans SJ, Nigrin DJ, Mandl KD. Whose personal control? Creating private, personally controlled health records for pediatric and adolescent patients. J Am Med Inform Assoc. 2008 Nov-Dec; 15(6):737-43.
Taylor PL. Rules of engagement. Nature. 2007 Nov 8; 450(7167):163-4.
Taylor P, Bourgeois FC, Mandl KD. Access controls for a pediatric personally controlled health record. AMIA Annu Symp Proc. 2007; 1131.
Hyun I, Taylor P, Testa G, Dickens B, Jung KW, McNab A, Robertson J, Skene L, Zoloth L. Ethical standards for human-to-animal chimera experiments in stem cell research. Cell Stem Cell. 2007 Aug 16; 1(2):159-63.
Kohane IS, Mandl KD, Taylor PL, Holm IA, Nigrin DJ, Kunkel LM. Medicine. Reestablishing the researcher-patient compact. Science. 2007 May 11; 316(5826):836-7.
Taylor PL. Research sharing, ethics and public benefit. Nat Biotechnol. 2007 Apr; 25(4):398-401.
Schlaeger TM, Lensch MW, Taylor PL. Science aside: the trajectory of embryonic stem cell research in the USA. Drug Discov Today. 2007 Apr; 12(7-8):269-71.
Daley GQ, Ahrlund Richter L, Auerbach JM, Benvenisty N, Charo RA, Chen G, Deng HK, Goldstein LS, Hudson KL, Hyun I, Junn SC, Love J, Lee EH, McLaren A, Mummery CL, Nakatsuji N, Racowsky C, Rooke H, Rossant J, Schöler HR, Solbakk JH, Taylor P, Trounson AO, Weissman IL, Wilmut I, Yu J, Zoloth L. Ethics. The ISSCR guidelines for human embryonic stem cell research. Science. 2007 Feb 2; 315(5812):603-4.
Bourgeois F, Taylor P, Mandl K. A proposed legal framework for addressing privacy for patient controlled health records in pediatrics. AMIA Annu Symp Proc. 2006; 861.
Taylor PL. The gap between law and ethics in human embryonic stem cell research: overcoming the effect of U.S. federal policy on research advances and public benefit. Sci Eng Ethics. 2005 Oct; 11(4):589-616.
Taylor PL. Clinical Researcher. IRB and Institutional Roles and Remedies in Managing Conflicts of Interest in Industry-Sponsored Academic Research. 2004; 3(4):2-6.
Taylor PL. Academic Medicine. Clinical Integration and New Options for Academic Medical Institutions in Network Development. 1999; (74):213-220.